Research use only 99%+ purity guaranteed Third-party COA tested UK tracked delivery
BPC-157 + TB-500 10 mg research blend vial

Dual-peptide research blend

BPC-157 + TB-500

10 mg total

5 mg BPC-157 5 mg TB-500 Comparative signalling research

A 10 mg dual-peptide research blend containing 5 mg BPC-157 and 5 mg TB-500 for controlled comparative work across short-peptide signalling, actin dynamics and cell-migration models.

Presentation Lyophilised research material
Strength 10 mg total
Use boundary Research only
Material type Two-component synthetic peptide blend
Research focus Cell signalling / actin dynamics

£25.00

Third Party COA tested. Please contact us for reports.

Build Up Add-On available at checkout for £25 per selected item.

Research-use information only. Not presented for human or veterinary administration.

QUALITY ASSURANCE

Third-party COA testing

Third Party COA tested. Please contact us for reports.

ABOUT THE COMPOUND

Description & research context

This research blend contains two separately designated peptide materials in one 10 mg vial: 5 mg BPC-157 and 5 mg TB-500. It is presented for controlled comparative studies where a fixed 1:1 labelled-mass composition is useful to the experimental design.

BPC-157 is commonly examined in short-peptide and cell-signalling models, while TB-500 is associated with actin-binding and cell-migration research. Results from a combined preparation require suitable controls because component identity, concentration and assay conditions can each affect interpretation.

APPLICATIONS IN RESEARCH

Common experimental themes

  • Comparative BPC-157 and TB-500 pathway research
  • Short-peptide signalling and actin-dynamics models
  • Cell migration and cell-matrix interaction studies
  • Analytical verification of two-component peptide preparations

LABORATORY HANDLING

Handling & stability

  • Handle dry lyophilised material using standard laboratory technique.
  • Select an aqueous or buffered vehicle appropriate to the assay design.
  • Avoid vigorous agitation during dissolution.
  • Use aliquots where suitable and minimise repeated freeze-thaw cycles.
  • Protect prepared material from prolonged light and elevated temperature.

RESEARCH NOTES

Interpretation & precautions

  • Use single-component controls where the study needs component-specific interpretation.
  • Appropriate positive and negative controls are recommended for signalling studies.
  • Reference literature is mechanistic and preclinical; observations are not clinical outcomes.
  • For laboratory research use only.

REFERENCE READING

Published and technical sources

Open WhatsApp